Downregulation of beta-catenin in chemo-tolerant TNBC through changes in receptor and antagonist profiles of the WNT pathway: Clinical and prognostic implications-Reference-Cited by-同舟云学术

Downregulation of beta-catenin in chemo-tolerant TNBC through changes in receptor and antagonist profiles of the WNT pathway: Clinical and prognostic implications

Published:2020-05-19 Issue:4 Volume:43 Page:725-741
ISSN:2211-3428
Container-title:Cellular Oncology
language:en
Short-container-title:Cell Oncol.

Author:

Islam Saimul,Dasgupta Hemantika,Basu Mukta,Roy Anup,Alam Neyaz,Roychoudhury Susanta,Panda Chinmay Kumar

Funder

University Grant Commission india

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Molecular Medicine,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s13402-020-00525-5.pdf

Reference61 articles.

1. W.D. Foulkes, I.E. Smith, J.S. Reis-Filho, Triple-negative breast cancer. N. Engl. J. Med. 363, 1938–1948 (2010)

2. E.K. Millar, P.H. Graham, S.A. O’Toole, C.M. McNeil, L. Browne, A.L. Morey, S. Eggleton, J. Beretov, C. Theocharous, A. Capp, E. Nasser, J.H. Kearsley, G. Delaney, G. Papadatos, C. Fox, R.L. Sutherland, Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel. J. Clin. Oncol. 27, 4701–4708 (2009)

3. K.D. Voduc, M.C. Cheang, S. Tyldesley, K. Gelmon, T.O. Nielsen, H. Kennecke, Breast cancer subtypes and the risk of local and regional relapse. J. Clin. Oncol. 28, 1684–1691 (2010)

4. P. Samadi, S. Saki, F.K. Dermani, M. Pourjafar, M. Saidijam, Emerging ways to treat breast cancer: will promises be met? Cell. Oncol. 41, 605–621 (2018)

5. M.L. Pecero, J. Salvador-Bofill, S. Molina-Pinelo, Long non-coding RNAs as monitoring tools and therapeutic targets in breast cancer. Cell. Oncol. 42, 1–12 (2018)

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dkk1 as a Prognostic Marker for Neoadjuvant Chemotherapy Response in Breast Cancer Patients;Cancers;2024-01-18

2. Role of MLH1 and MSH2 deficiency in the development of tumorigenesis and chemo-tolerance of cervical Carcinoma: Clinical implications;Gene;2023-12

3. Down-regulation of FA-BRCA Pathway in Cervical Carcinoma Gradually Reversed During the Development of Chemo-tolerance: Clinical Implications;Reproductive Sciences;2023-11-27

4. Discovery of a first-in-class ANXA3 degrader for the treatment of triple-negative breast cancer;Acta Pharmaceutica Sinica B;2023-04

5. High nuclear expression of DNMT1 in correlation with inactivation of TET1 portray worst prognosis among the cervical carcinoma patients: clinical implications;Journal of Molecular Histology;2023-01-24